Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms
Treatment of infectious diseases becomes more challenging with each passing year. This is
especially true for infections caused by the opportunistic pathogen Pseudomonas …
especially true for infections caused by the opportunistic pathogen Pseudomonas …
Pseudomonas Aeruginosa: Arsenal of Resistance Mechanisms, Decades of Changing Resistance Profiles, and Future Antimicrobial Therapies
ME El Zowalaty, AA Al Thani, TJ Webster… - Future …, 2015 - Taylor & Francis
Antimicrobial resistance is one of the most serious public health issues facing humans since
the discovery of antimicrobial agents. The frequent, prolonged, and uncontrolled use of …
the discovery of antimicrobial agents. The frequent, prolonged, and uncontrolled use of …
Trends in Antimicrobial Resistance among Urinary Tract Infection Isolates of Escherichia coli from Female Outpatients in the United States
JA Karlowsky, LJ Kelly, C Thornsberry… - Antimicrobial agents …, 2002 - Am Soc Microbiol
ABSTRACT The Infectious Diseases Society of America advocates trimethoprim-
sulfamethoxazole (SXT) as initial therapy for females with acute uncomplicated bacterial …
sulfamethoxazole (SXT) as initial therapy for females with acute uncomplicated bacterial …
Severe sepsis and septic shock: review of the literature and emergency department management guidelines
Severe sepsis and septic shock are as common and lethal as other acute life-threatening
conditions that emergency physicians routinely confront such as acute myocardial infarction …
conditions that emergency physicians routinely confront such as acute myocardial infarction …
Surveillance for Antimicrobial Susceptibility among Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from Hospitalized Patients in the …
JA Karlowsky, DC Draghi, ME Jones… - Antimicrobial agents …, 2003 - Am Soc Microbiol
Pseudomonas aeruginosa and Acinetobacter baumannii are the most prevalent
nonfermentative bacterial species isolated from clinical specimens of hospitalized patients …
nonfermentative bacterial species isolated from clinical specimens of hospitalized patients …
Competency in cardiac examination skills in medical students, trainees, physicians, and faculty: a multicenter study
JM Vukanovic-Criley, S Criley, CM Warde… - Archives of internal …, 2006 - jamanetwork.com
Background Cardiac examination is an essential aspect of the physical examination.
Previous studies have shown poor diagnostic accuracy, but most used audio recordings …
Previous studies have shown poor diagnostic accuracy, but most used audio recordings …
[HTML][HTML] Global prevalence and distribution of antibiotic resistance among clinical isolates of Stenotrophomonas maltophilia: a systematic review and meta-analysis
Objectives Stenotrophomonas maltophilia (S. maltophilia), an opportunistic pathogen,
causes infection in patients undergoing immunosuppressive therapy, mechanical …
causes infection in patients undergoing immunosuppressive therapy, mechanical …
[PDF][PDF] Multidrug-Resistant Acinetobacter spp.: Increasingly Problematic Nosocomial Pathogens
K Lee, D Yong, SH Jeong… - Yonsei medical journal, 2011 - synapse.koreamed.org
Pathogenic bacteria have increasingly been resisting to antimicrobial therapy. Recently,
resistance problem has been relatively much worsened in Gram-negative bacilli …
resistance problem has been relatively much worsened in Gram-negative bacilli …
Antimicrobial resistance trends and outbreak frequency in United States hospitals
DJ Diekema, BJ BootsMiller, TE Vaughn… - Clinical infectious …, 2004 - academic.oup.com
We assessed resistance rates and trends for important antimicrobial-resistant pathogens
(oxacillin-resistant Staphylococcus aureus [ORSA], vancomycin-resistant Enterococcus …
(oxacillin-resistant Staphylococcus aureus [ORSA], vancomycin-resistant Enterococcus …
Levofloxacin: a review of its use in the treatment of bacterial infections in the United States
KF Croom, KL Goa - Drugs, 2003 - Springer
Levofloxacin (Levaquin®) is a fluoroquinolone antibacterial agent with a broad spectrum of
activity against Gram-positive and Gram-negative bacteria and atypical respiratory …
activity against Gram-positive and Gram-negative bacteria and atypical respiratory …